Drug Formulary Update, April 2017 Commercial and State Programs
|
|
- Mae McCarthy
- 5 years ago
- Views:
Transcription
1 Drug Formulary Update, April 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx, GenericsPlusRx, EnhancedRx, and GenericsAdvantageRx) and to HealthPartners Minnesota Health Care Programs (Medicaid and Minnesota Care State Programs ) Drug Formulary. Please see for details. Positive changes (additions) are generally effective April 1, and negative changes (deletions) are generally effective July 1. Additional communications are sent to members and providers affected by negative changes. Adapalene 0.1 % gel F NF 7/1/17 Adapalene 0.1% gel as a prescription medication is being removed from the Differin OTC is being added to the formulary as a replacement, and will be covered for a generic co pay. Arformoterol nebulization (Brovana) NF NF PA 7/1/17 Brovana will be reserved for patients with an inadequate response to a preferred product, with significant Azilsartan (Edarbi and Edarbyclor) NF PA Update 4/1/17 Azilsartan is reserved for patients with an inadequate response to two or more preferred products (losartan, irbesartan, and valsartan), with improved Balsalazide (Colazal), Brandonly NF NF PA 7/1/17 Colazal Brand will be reserved for
2 HealthPartners Formulary Update, page 2 of 9 Benzoyl peroxide NF NF PA 7/1/17 Several strengths will be reserved for to preferred products (benzoyl peroxide OTC), with significant clinical rationale suggesting improved This change applies to the 8% gel, 6% towelette, 4% gel, 7% cleanser, 9.8% foam, 5.3% foam, 9.8 % foam, and 5.3% foam. Budesonide nebulization suspension F AE F AE PA 4/1/17 Coverage criteria have been added for eosinophilic esophagitis. For eosinophilic esophagitis, budesonide nebulization is reserved for to swallowed fluticasone. Budesonide nebulization continues to be available for children <= age 8 (no restrictions). Inhaled steroids are preferred for asthma for older children and adults. Clindamycin 1%/ benzoyl peroxide 5% gel pump Clindamycin/ tretinoin Brands NF NF PA 7/1/17 Clindamycin 1%/ benzoyl peroxide 5% gel will be reserved for patients who have tried preferred products, with improved Clindamycin gel remains on formulary, and benzoyl peroxide is available OTC. NF NF PA 7/1/17 Clindamycin/ tretinoin Brands will be reserved for patients with an inadequate response to generic clindamycin/ tretinoin, with significant Note: Generic clindamycin/ tretinoin is non Individual products given separately are preferred. This change applies to Veltin and Ziana.
3 HealthPartners Formulary Update, page 3 of 9 Desloratadine (Clarinex), NF NF PA* 7/1/17 Clarinex Brand will be reserved for * Clarinex remains excluded for the Desonide, NF NF PA 7/1/17 Desonide Brands will be reserved for to two or more preferred products, with significant clinical rationale suggesting improved This change applies to Desonate gel and Verdeso foam. Desoximetasone (Topicort) spray NF NF PA 7/1/17 Topicort spray will be reserved for to two or more preferred products, with significant clinical rationale suggesting improved Dexlansoprazole (Dexilant) NF NF PA* 7/1/17 Dexilant will be reserved for patients improved * Dexilant remains excluded for the Diflorasone NF NF PA 7/1/17 Diflorasone will be reserved for patients improved Diltiazem (Cardizem CD) 120mg NF NF PA 7/1/17 Cardizem CD (all strengths) will be reserved for patients with an inadequate response to the equivalent generic due to a documented allergic reaction. Econazole F NF 7/1/17 Econazole will be removed from the
4 HealthPartners Formulary Update, page 4 of 9 Escitalopram (Lexapro), NF NF PA 7/1/17 Lexapro Brands will be reserved for to the equivalent generic due to a documented allergic reaction. Fenofibrate NF NF PA 7/1/17 Several forms of fenofibrate will be reserved for patients with an inadequate response to preferred products, with significant clinical rationale suggesting improved This change applies to Fenoglide, Antara, and fenofibrate 120mg tablet. Most fenofibrate generics remain on Fioricet Brands NF QL NF QL PA 7/1/17 Fioricet Brands will be reserved for This change applies to Fioricet (butalbital/ acetaminophen/ caffeine) and Fioricet with codeine (codeine/ butalbital/ acetaminophen/ caffeine). Fluocinolone shampoo (Capex) NF NF PA 7/1/17 Capex will be reserved for patients with an inadequate response to two or more Flurandrenolide NF NF PA 7/1/17 Most forms of flurandrenolide will be reserved for patients with an inadequate response to two or more This change applies to flurandrenolide cream, lotion, and ointment. Cordran tape remains on formulary with prior authorization.
5 HealthPartners Formulary Update, page 5 of 9 Formoterol (Foradil) F NF 4/1/17 Foradil has been removed from the Formoterol nebulization (Perforomist) Glycopyrrolate (Robinul), NF NF PA 7/1/17 Perforomist will be reserved for to a preferred product, with significant NF NF PA 7/1/17 Robinul Brands will be reserved for Halcinonide (Halog) NF NF PA 7/1/17 Halog will be reserved for patients with an inadequate response to two or more Hydrocortisone rectal foam (Cortifoam) NF NF PA 7/1/17 Cortifoam will be reserved for patients with an inadequate response to a preferred product, with significant Hydrocortisone suppositories remain on Insulin inhaled (Afrezza) NF NF PA 7/1/17 Afrezza will be reserved for patients with an inadequate response to preferred products. Isotretinoin (Absorica) NF QL NF PA QL 7/1/17 Absorica will be reserved for patients with a documented allergic reaction to the equivalent generic. Ivermectin (Soolantra) cream NF PA Update 4/1/17 Soolantra is reserved for patients with an inadequate response to two or more preferred products (metronidazole, sulfacetamide sulfur, doxycycline or minocycline, tretinoin, or adapalene).
6 HealthPartners Formulary Update, page 6 of 9 Lactulose (Kristalose) packet NF NF PA 7/1/17 Kristalose packet will be reserved for to lactulose solution, with significant Lactulose solution remains on Lamotrigine (Lamictal and Lamictal XR), NF NF PA 7/1/17 Lamictal Brands will be reserved for to the equivalent generic due to a documented allergic reaction. Lesinurad (Zurampic) NF NF PA 7/1/17 Zurampic will require prior authorization. Levocetirizine (Xyzal), Brandonly NF NF PA* 7/1/17 Xyzal Brand will be reserved for patients with a documented allergic reaction to the equivalent generic. * Xyzal remains excluded for the Lomotil (diphenoxylate/ atropine), NF QL NF QL PA 7/1/17 Lomotil Brands will be reserved for Miconazole (Vusion) ointment NF NF PA 7/1/17 Vusion will be reserved for patients improved Naftifine (Naftin) gel NF NF PA 7/1/17 Naftin gel will be reserved for patients improved
7 HealthPartners Formulary Update, page 7 of 9 Olmesartan NF PA NF 4/1/17 Olmesartan is non This applies to olmesartan, olmesartan/ HCTZ, olmesartan amlodipine, and olmesartan/ amlodipine/ HCTZ. Benicar, Benicar HCT, Azor, and Tribenzor Brands remain non formulary with prior authorization. Olsalazine (Dipentum) NF NF PA 7/1/17 Dipentum will be reserved for patients improved Oxiconazole (Oxistat) NF NF PA 7/1/17 Oxistat will be reserved for patients improved Pantoprazole (Protonix) granules NF PA NF* 4/1/17 Protonix is non Protonix remains excluded for the Pramipexole ER F PA Update 4/1/17 Pramipexole ER is reserved for patients with Parkinson s disease who have significant side effects, loss of effectiveness or compliance concerns with regular release pramipexole. Propranolol Brands NF NF PA 7/1/17 Propranolol Brands will be reserved for to This applies to Inderal XL, InnoPran XL, and Inderal LA.
8 HealthPartners Formulary Update, page 8 of 9 Quetiapine ER F PA Update 4/1/17 Quetiapine ER is reserved for patients with documented compliance concerns with quetiapine regular release; or for patients previously stable on this medication. Approvals are given for five years. Reauthorizations are given to patients who have been seen within the previous 14 months, and who continue to need this medication. Quetiapine XR (Seroquel XR), NF PA Update 4/1/17 Seroquel XR Brand is reserved for reaction to the generic equivalent. Approvals are given for one year. Reauthorizations are given to patients who have been seen within the previous 14 months, and who continue to need this medication, and can t use the generic equivalent. Rabeprazole (Aciphex Sprinkle) NF NF PA* 7/1/17 Aciphex Sprinkle will be reserved for to two or more preferred products, with significant clinical rationale suggesting improved Rabeprazole tablets remain on * Aciphex remains excluded for the Ranitidine syrup F AE F 4/1/17 Ranitidine syrup is on Rosuvastatin (Crestor), NF NF PA 7/1/17 Crestor Brand will be reserved for to the equivalent generic due to a documented allergic reaction.
9 HealthPartners Formulary Update, page 9 of 9 Sulconazole (Exelderm) F NF 7/1/17 Exelderm will be removed from PreferredRx and EnhancedRx formularies, and is non formulary for all formularies. Sulfacetamide/ sulfur (BP 10 1) Tacrolimus (Protopic), F NF PA 7/1/17 BP 10 1 will be reserved for patients with an inadequate response to preferred sulfacetamide/ sulfur products, with significant clinical rationale suggesting improved NF NF PA 7/1/17 Protopic Brand will be reserved for Ursodiol (Actigall) Brand NF NF PA 7/1/17 Actigall Brand will be reserved for to the equivalent generic due to a documented allergic reaction. Vanatol (butalbital/ acetaminophen/ caffeine) NF NF PA 7/1/17 Vanatol will be reserved for patients with an inadequate response to two Zubsolv (buprenorphine/ naloxone) NF QL NF QL PA 7/1/17 Zubsolv will be reserved for patients with an inadequate response to Suboxone film and buprenorphine/ naloxone tablets remain on
Drug Formulary Update, January 2017 Commercial and State Programs
Drug Formulary Update, January 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationHigh-Cost Drug Exclusions
PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationDrug Formulary Update, January 2018 Commercial and State Programs
Drug Formulary Update, January 2018 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationHigh-Cost Drug Exclusions
Pharmacy Services High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationHigh-Cost Drug Exclusions
PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019
Step Therapy Requirements Effective April 1, 2019 ANTIEMETICS STEP Sancuso 3.1 mg/24 hour transdermal patch Zuplenz 4 mg oral soluble film Zuplenz 8 mg oral soluble film COVERAGE OF CERTAIN BRAND NAME
More informationALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018
Step Therapy Requirements Effective April 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone
More informationALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018
Step Therapy Requirements Effective June 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone
More informationDrug Formulary Update, October 2016 Commercial and State Programs
Drug Formulary Update, October 2016 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More information2018 Step Therapy FID 18088
2018 Step Therapy FID 18088 Step Therapy ANTIDEPRESSANTS, SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS LEON 2018 Desvenlafaxine Er Fetzima Fetzima Titration Pack Khedezla Paxil SUSP Pristiq Trintellix
More informationALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017
ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone 15 mg tablet alogliptin 12.5 mg-pioglitazone
More informationComparison of representative topical corticosteroid preparations (classified according to the US system)
Comparison of representative topical corticosteroid preparations (classified according to the US system) Potency group* Corticosteroid Vehicle type/form Trade names (United States) Available strength(s),
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end
More informationStep Therapy Criteria 2019
Step Therapy 2019 For information on obtaining an updated coverage determination or an exception to a coverage determination please call Freedom Health Member Services at 1-800-401-2740 or, for TTY/TDD
More informationRelative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
More informationDrug Formulary Update, July 2016 Commercial and State Programs
Drug Formulary Update, July 2016 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationPrepared for Regence BlueCross BlueShield of Oregon Producers Only. Not intended for distribution to Regence consumers or members.
Revised date: 10/17/16 Issue Brief: Jan. 1, 2017, Formulary Changes OmedaRx regularly evaluates the performance and impact of medications using one of the most rigorous, evidence-based assessment processes
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
More informationLABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION
LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION Added Prior Authorization 7/1/17 CORLANOR 5 MG TABLET Added Prior Authorization 7/1/17 CORLANOR 7.5 MG TABLET Added Prior Authorization 7/1/17
More informationQuarterly pharmacy formulary change notice
Provider Bulletin June 2017 The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. These changes were reviewed and approved at the first quarter Pharmacy and Therapeutics
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.
More informationComparison of representative topical corticosteroid preparations (classified according to the US system)
Comparison of representative topical corticosteroid preparations (classified according to the US system) Potency group* Corticosteroid Vehicle type/form Trade names (United States) Available strength(s),
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Drugs / Biologics Not Covered Unless Approved Under Medical Necessity Review Employer Group Plans: Value Prescription Drug List and Advantage Prescription
More informationNeighborhood Medicaid Formulary Changes: June 2017
Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were
More informationSmithRx Standard Formulary Step Therapy List
SmithRx Standard Formulary Step Therapy List Revised: January 27, 2017 The following medications require prior use of at least one other medication for coverage. Please note that any plan-specific customizations
More informationANGIOTENSIN RECEPTOR BLOCKERS
Step Therapy 2014 2 Tier-Alameda Last Updated: 10/10/2014 ANGIOTENSIN RECEPTOR BLOCKERS Benicar Benicar Hct Diovan Valsartan Step 1: First line therapy should be irbesartan, irbesartan/hctz, losartan,
More informationDrug Formulary Update, October 2013
Drug Formulary Update, October 2013 Updates to the HealthPartners Drug Formularies are listed below. Updates for the Commercial Drug Formularies and the Minnesota Health Care Programs (Medicaid and Minnesota
More informationOregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, HealthNow New York Inc. requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.
More informationMercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
More informationTherapeutic Class Not Covered Examples of alternative options Analgesics - Anti-Inflammatory Nonsteroidal Anti-Inflammatory Agents (NSAIDS)
Date last updated: 3/23/18 Your benefit plan does not cover all drugs. Your benefit plan excludes coverage for drugs with one or more principal ingredients that are already available in greater/lesser
More informationDrug Formulary Update, January 2013
Drug Formulary Update, January 2013 Updates to the HealthPartners Drug Formularies are listed below. Updates for the Commercial Drug Formularies and the Minnesota Health Care Programs (Medicaid and Minnesota
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.
More information2016 PRESCRIPTION DRUG LIST UPDATES
2016 PRESCRIPTION DRUG LIST UPDATES Evergreen Health 1 st Quarter Below are key updates to the four-tier EHB Prescription Formulary, effective January 1, 2016. Please consult the full formulary for more
More informationThe Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More informationUpdates to your prescription benefits Effective January 1, 2015
Updates to your prescription benefits Effective January 1, 2015 Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount your covered employees pay when they
More informationPrescription benefit updates Large group
Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
More informationTherapeutic Class Not Covered Examples of alternative options Analgesics - Anti-Inflammatory Nonsteroidal Anti-Inflammatory Agents (NSAIDS)
Date last updated: 6/11/18 Your benefit plan does not cover all drugs. Your benefit plan excludes coverage for drugs with one or more principal ingredients that are already available in greater/lesser
More informationMedication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017
More informationUPDATE WellCare s South Carolina
September 3, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the September 3, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes
More informationProton Pump Inhibitors
Market DC Proton Pump Inhibitors Override(s) Prior Authorization Quantity Limit** Approval Duration Preferred PPI: No Prior Authorization required Preferred PPI quantity override: Lifetime Non-Preferred
More informationMercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
More informationEffective for all members on August 1, 2017
August 2017 Pharmacy Formulary Change Notice BlueChoice HealthPlan Medicaid is here to help you stay on top of your health care. We want to tell you about some upcoming changes to your Preferred Drug List
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201056 NOVEMBER 30, 2010 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the November 19, 2010, Drug Utilization
More informationRationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)
BLUE SHIELD OF CALIFORNIA FIRST QUARTER 2015 FORMULARY AND MEDICATION POLICY UPDATES EFFECTIVE MARCH 19, 2015 The Blue Shield of California (BSC) Pharmacy and Therapeutics (P&T) Committee, consisting of
More informationProduct List Finished Dosage Forms (FDF) B2B Business
Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium
More informationPharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017
Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017 DRUG LIST CHANGES Based on the availability of new prescription medications and Prime s National Pharmacy and Therapeutics Committee
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
More informationAdvanced Control Formulary Change Summary Report Effective
This report highlights all changes (additions, deletions, and removals) to the CVS Caremark Advanced Control Formulary. ADDITIONS: Brand Agents: Ajovy (fremanezumabvfrm) subcutaneous injection Aristada
More informationStep Therapy Medications
Step Therapy Medications Step Therapy (ST PA ) is an automated form of prior authorization. It encourages the use of therapies that should be tried first, before other treatments are covered, based on
More informationHealth Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
More informationALLERGIC RHINITIS-NASAL
ALLERGIC RHINITIS-NASAL FLUNISOLIDE Patient needs to have paid claims for any one of the following Step 1 drugs: NasaCort OTC, fluticasone Rx, fluticasone OTC, Budesonide OTC. Prior to filling the Step
More informationUF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008
UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 Promoting high quality, cost effective drug therapy throughout the Military Health System UF Decisions, May 07 Class FY05 rank, total $
More informationTable 1: Price increases for Brand Name Drugs with Generic Equivalents
Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%
More informationMichigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan
Michigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan Agenda: Introductions Approval of Minutes of July 8, 2014 Meeting P & T Business Review
More informationSTEP THERAPY ALGORITHMS PUP Select Formulary
The Step Therapy drug will be dispensed if the drug has been dispensed within 120 days of current fill or if alternative (Step 1) drugs have been used first. If the member s prescription claim fails the
More informationANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.25 Subject: Eucrisa Page: 1 of 6 Last Review Date: September 15, 2017 Eucrisa Description Eucrisa
More informationAetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
More informationUpdates to your prescription benefits
Updates to your prescription benefits Effective Jan. 1, 2018 Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill
More information1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 1/1/19, Cigna is making changes to our formularies that may impact medication coverage for customers at your pharmacy. We have included a
More informationOHIO MEDICAID PHARMACY COVERAGE
OHIO MEDICAID PHARMACY COVERAGE This information is intended for use by providers to help select the most appropriate cost-effective medication and formulation for their patients. Prescribers should utilize
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Eucrisa Page: 1 of 7 Last Review Date: June 22, 2018 Eucrisa Description Eucrisa (crisaborole)
More informationYour prescription benefit updates Formulary Updates - Effective January 1, 2019
Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will
More informationBLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
More informationANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI 10 MG-5 MG GLYXAMBI 25 MG-5 MG INVOKAMET 150 MG-1,000 MG INVOKAMET 150 MG-500 MG INVOKAMET 50 MG-1,000 MG INVOKAMET 50 MG-500 MG INVOKAMET XR 150 MG-1,000 MG,
More informationBLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
More informationANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY
South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5
More information2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
More informationPHARMA-MEDIC SERVICES INC. POLICY MANUAL
PHARMA-MEDIC SERVICES INC. POLICY MANUAL SUBJECT: INDEX: P.5.a.iii Automatic-Therapeutic Substitution DATE: June 1/2011 REVISED: March 2, 2015., Feb 2017. PROCEDURE: 1. Long term care homes use the Manitoba
More information2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
More informationPrescription Step Therapy Program
Prescription Step Therapy Program 04HQ3972 R11/17 Blue Cross and Blue Shield of Louisiana is incorporated as Louisiana Health Service & Indemnity Company. HMO Louisiana, Inc. is a subsidiary of Blue Cross
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationAcyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria
Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time
More informationPharmacy Benefit Determination Policy
Policy Subject: Atopic Dermatitis Agents Policy Number: SHS PBD18 Category: Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS PPO ASO s:
More informationANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
More informationThe Weekly Mortar & Pestle
The Weekly Mortar & Pestle A Publication of Walgreens Health Initiatives February 7, 2008 A publication created especially for our clients and associates, delivering up-to-date information about brand-name
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More informationStep Therapy Requirements. Effective: 03/01/2015
Effective: 03/01/2015 Updated 02/2015 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA OXTELLAR XR POTIGA QUDEXY
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2116-3 Program Prior Authorization/Medical Necessity Medications Dupixent (dupilumab) P&T Approval Date 1/2017, 5/2017, 7/2017
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
More informationUpdates to the Alberta Drug Benefit List. Effective September 1, 2018
Updates to the Alberta Drug Benefit List Effective September 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
More informationStep Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)
CareAdvantage CMC 2018 Formulary Supplement II (List of Covered Drugs) Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs) Formulary ID: 00018157 Formulary Version:11 19 CMS Approved: 08/21/2018
More information2015 Step Therapy Prior Authorization Medical Necessity Guidelines
Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154
More informationFORMULARY NOTES ABOUT FORMULARY AND PHARMACY
FORMULARY NOTES ABOUT FORMULARY AND PHARMACY 1. Purposes: Assist team leaders in preparing for trips Limit the number of interchangeable drugs Limit pharmacy errors Improve efficiency and organization
More informationExcluded Drug Name. Tablet Delayed Release. Lozenge on a Handle
Abilify Absorica Abstral Acanya Accolate Aciphex Aciphex Sprinkle Acticlate Actiq Actonel Actos Adapalene Adderall Adderall XR Adrenaclick Page 1 of 9 Sublingual Delayed Release Sprinkle Lozenge on a Handle
More informationADHD STIMULANTS-S(SHC)
Step Therapy Simply Health Care 2014 Formulary ID: 14406 Version: 14 Last Updated: 08/01/2014 ADHD STIMULANTS-S(SHC) Daytrana Focalin Xr Strattera Patient needs to have a paid claim for one Step 1 drug
More informationUWSP Student Health Service Pharmacy Formulary 1/22/2015
UWSP Student Health Service Pharmacy Formulary 1/22/2015 UWSP Student Health Service Pharmacy Formulary 1/22/2015 Medication Name Strength DosageForm Route Acetaminophen 325 MG Tablet Oral Acetaminophen-Codeine
More information